These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 39415072)

  • 1. Identifying Patients With Primary Biliary Cholangitis and Cirrhosis Using Administrative Data in a National Cohort.
    John BV; Bastaich D; Dahman B;
    Pharmacoepidemiol Drug Saf; 2024 Oct; 33(10):e70013. PubMed ID: 39415072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
    Burkholder DA; Moran IJ; DiBattista JV; Lok AS; Parikh ND; Chen VL
    Dig Dis Sci; 2022 Aug; 67(8):3623-3631. PubMed ID: 34674069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data.
    Niu B; Forde KA; Goldberg DS
    Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):107-11. PubMed ID: 25335773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies.
    Hayward KL; Johnson AL; Mckillen BJ; Burke NT; Bansal V; Horsfall LU; Hartel G; Moser C; Powell EE; Valery PC
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32943463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
    Efe C; Taşçilar K; Henriksson I; Lytvyak E; Alalkim F; Trivedi H; Eren F; Eliasson J; Beretta-Piccoli BT; Fischer J; Calişkan AR; Chayanupatkul M; Coppo C; Ytting H; Purnak T; Muratori L; Werner M; Muratori P; Rorsman F; Önnerhag K; Günşar F; Nilsson E; Heurgué-Berlot A; Güzelbulut F; Demir N; Gönen C; Semela D; Aladağ M; Kiyici M; Schiano TD; Montano-Loza AJ; Berg T; Ozaslan E; Yoshida EM; Bonder A; Marschall HU; Wahlin S
    Am J Gastroenterol; 2019 Jul; 114(7):1101-1108. PubMed ID: 31241547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of coding algorithms for the identification of patients with primary biliary cirrhosis using administrative data.
    Myers RP; Shaheen AA; Fong A; Wan AF; Swain MG; Hilsden RJ; Sutherland L; Quan H
    Can J Gastroenterol; 2010 Mar; 24(3):175-82. PubMed ID: 20352146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dahiya M; Eboreime E; Hyde A; Rahman S; Sebastianski M; Carbonneau M; Tapper EB; Tandon P
    Dig Dis Sci; 2022 Jun; 67(6):2107-2122. PubMed ID: 34091800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
    Ampuero J; Lucena A; Berenguer M; Hernández-Guerra M; Molina E; Gómez-Camarero J; Valdivia C; Gómez E; Casado M; Álvarez-Navascuez C; Jorquera F; García-Buey L; Díaz-González Á; Morillas R; García-Retortillo M; Sousa JM; Pérez-Medrano I; Simón MÁ; Martínez J; Arenas J; Londoño MC; Olveira A; Fernández-Rodríguez C;
    Hepatology; 2024 Oct; 80(4):791-806. PubMed ID: 38447019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of administrative claims data for identifying patients with cirrhosis.
    Nehra MS; Ma Y; Clark C; Amarasingham R; Rockey DC; Singal AG
    J Clin Gastroenterol; 2013; 47(5):e50-4. PubMed ID: 23090041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of International Classification of Diseases, Tenth Revision, Codes for Cirrhosis.
    Ramrakhiani NS; Le MH; Yeo YH; Le AK; Maeda M; Nguyen MH
    Dig Dis; 2021; 39(3):243-246. PubMed ID: 32814313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary biliary cholangitis : therapeutic and evolving aspects about 46 cases.
    Loghmari MH; Jemmali D; Ben Mansour W; Guediche A; Bouhlel W; Safer L
    Tunis Med; 2018 Jan; 96(1):12-17. PubMed ID: 30324986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems.
    Lu M; Li J; Haller IV; Romanelli RJ; VanWormer JJ; Rodriguez CV; Raebel MA; Boscarino JA; Schmidt MA; Daida YG; Sahota A; Vincent J; Bowlus CL; Lindor K; Rupp LB; Gordon SC;
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1333-1341.e6. PubMed ID: 29066370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
    Corpechot C; Chazouillères O; Belnou P; Montano-Loza AJ; Mason A; Ebadi M; Eurich D; Chopra S; Jacob D; Schramm C; Sterneck M; Bruns T; Reuken P; Rauchfuss F; Roccarina D; Thorburn D; Gerussi A; Trivedi P; Hirschfield G; McDowell P; Nevens F; Boillot O; Bosch A; Giostra E; Conti F; Poupon R; Parés A; Reig A; Donato MF; Malinverno F; Floreani A; Russo FP; Cazzagon N; Verhelst X; Goet J; Harms M; van Buuren H; Hansen B; Carrat F; Dumortier J;
    J Hepatol; 2020 Sep; 73(3):559-565. PubMed ID: 32275981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    John BV; Khakoo NS; Schwartz KB; Aitchenson G; Levy C; Dahman B; Deng Y; Goldberg DS; Martin P; Kaplan DE; Taddei TH
    Am J Gastroenterol; 2021 Sep; 116(9):1913-1923. PubMed ID: 33989225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.
    Terziroli Beretta-Piccoli B; Stirnimann G; Cerny A; Semela D; Hessler R; Helbling B; Stickel F; Kalid-de Bakker C; Bihl F; Giostra E; Filipowicz Sinnreich M; Oneta C; Baserga A; Invernizzi P; Carbone M; Mertens J
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):295-306. PubMed ID: 29181702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatment.
    Sebode M; Kloppenburg A; Aigner A; Lohse AW; Schramm C; Linder R
    Z Gastroenterol; 2020 May; 58(5):431-438. PubMed ID: 32392605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of osteoporosis in patients with primary biliary cirrhosis.
    Liao CY; Chung CH; Chu P; Wei KY; Feng TM; Lin FH; Tsao CH; Wu CC; Chien WC
    PLoS One; 2018; 13(3):e0194418. PubMed ID: 29543880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased infiltration of CD4
    Yu K; Li P; Xu T; Xu J; Wang K; Chai J; Zhao D; Liu Y; Wang Y; Ma J; Fan L; Guo S; Li Z; Li M; Wang Z
    Pathol Res Pract; 2021 Jan; 217():153291. PubMed ID: 33249399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease.
    Cortez-Pinto H; Liberal R; Lopes S; Machado MV; Carvalho J; Dias T; Santos A; Agostinho C; Figueiredo P; Loureiro R; Martins A; Alexandrino G; Cotrim I; Leal C; Presa J; Mesquita M; Nunes J; Gouveia C; Vale AHE; Alves AL; Coelho M; Maia L; Pedroto I; Banhudo A; Pinto JS; Gomes MV; Oliveira J; Andreozzi V; Calinas F
    United European Gastroenterol J; 2021 Jul; 9(6):699-706. PubMed ID: 34102008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis.
    Tanaka A; Hirohara J; Nakano T; Matsumoto K; Chazouillères O; Takikawa H; Hansen BE; Carrat F; Corpechot C
    J Hepatol; 2021 Sep; 75(3):565-571. PubMed ID: 33882268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.